Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9.
Kwon T, Ra JS, Lee S, Baek IJ, Khim KW, Lee EA, Song EK, Otarbayev D, Jung W, Park YH, Wie M, Bae J, Cheng H, Park JH, Kim N, Seo Y, Yun S, Kim HE, Moon HE, Paek SH, Park TJ, Park YU, Rhee H, Choi JH, Cho SW, Myung K.
Kwon T, et al. Among authors: wie m.
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2103532119. doi: 10.1073/pnas.2103532119.
Proc Natl Acad Sci U S A. 2022.
PMID: 35217600
Free PMC article.